Cargando…
Inhibition of IL-1β Improves Fatigue in Type 2 Diabetes
Autores principales: | Cavelti-Weder, Claudia, Furrer, Romana, Keller, Cornelia, Babians-Brunner, Andrea, Solinger, Alan M., Gast, H., Fontana, A., Donath, Marc Y., Penner, Iris K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177746/ https://www.ncbi.nlm.nih.gov/pubmed/21949230 http://dx.doi.org/10.2337/dc11-1196 |
Ejemplares similares
-
Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy
por: Cavelti-Weder, Claudia, et al.
Publicado: (2012) -
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
por: Cavelti-Weder, Claudia, et al.
Publicado: (2012) -
Comment on: Lipsky and Berendt. Hyperbaric Oxygen Therapy for Diabetic Foot Wounds: Has Hope Hurdled Hype? Diabetes Care 2010;33:1143–1145
por: van der Staal, Sebastiaan R., et al.
Publicado: (2011) -
Increasing the Low-Glucose Alarm of a Continuous Glucose Monitoring System Prevents Exercise-Induced Hypoglycemia Without Triggering Any False Alarms
por: Iscoe, Katherine E., et al.
Publicado: (2011) -
Response to comment on: Löndahl et al. Hyperbaric Oxygen Therapy Facilitates Healing of Chronic Foot Ulcers in Patients With Diabetes. Diabetes Care 2010;33:998–1003
por: Löndahl, Magnus, et al.
Publicado: (2011)